AHIP CEO: ACA's Quality, Cost-Cutting Goals Unachievable If PhRMA Has 'Blank Check'

America's Health Insurance Plans CEO Karen Ignagni on Friday (Dec. 12) made another plea for drug makers to work with payers and providers to make pricing of specialty drugs more competitive and transparent, saying that absent such a a move changes in the health care landscape designed to increase quality and access while lowering costs may not be be sustainable in the long term. The Affordable Care Act has created a retail health care market in which consumers are focused...